Forgetfulness is common symptom with age. Especially for midlife women, hormonal cessation by menopausal change is one of the causes in cognitive disorders. And neuropathological changes in brain can lead to mild cognitive impairment (MCI) and eventually dementia. Prevention of MCI is important for decreasing progression to dementia. This article presents therapeutic approaches based on pathophysiologic changes in brain for preventing cognitive decline. 
Introduction
Cognitive disorders are classified as cognitive aging, mild cognitive impairment (MCI), and dementia. 1 Cognitive aging is physiologic forgetfulness and represents an erosion of existing abilities, beginning almost imperceptibly in middle age and accelerating during old age. 1 MCI is episodic memory loss without dementia. It is demonstrable memory impairment, but other cognitive abilities are not impaired and daily activities are largely intact. 1 Neurophysiological changes in the brain begin and clinical manifestations like cognitive decline are present with age, that`s defined as MCI. When these symptoms are persistent with cognitive impairment, it eventually will progress to dementia.
Dementia is major cognitive decline that has a substantial impact on occupational activities and other aspects of usual daily living. 1 Dementia is caused by various disease or conditions. The most common cause of dementia is Alzheimers disease (AD).
Ward et al. 2 reported that the prevalence of MCI is 31.9%
in Korean people older than 60 years. People with MCI are considered to be at risk for developing dementia, since research has shown that over half of those with MCI will develop dementia within 5 years, especially AD. 3 But it also means that some people with MCI seem to remain stable or return to normal over time. Thus MCI can be regarded as preclinical dementia, and the prevention of it is very important clinically.
Neuropathology
MCI is associated with the early stages of the neurobiological and neuropathological changes of AD;
including the accumulation of senile plaques, neurofibrillary tangles, synaptic and neurotransmitter associated deficits, and significant neuronal cell death. 4 These changes are thought to be related to the cause, development, and course of the disease.
Senile plaques, which are composed of β -amyloid polypeptides, seem to form as a result of disorders in processing β -amyloid and its precursor protein. 5 And the inflammation around plaques seem to destroy neighboring neurons. 5 Neuronal death in the brain plays a key role in
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AD progression and is directly linked to neuroinflammation.
Thus, the regulation of neuroinflammatory processes might be a practical strategy for the treatment of AD. 6 Neurofibrillary tangles are made up of a protein called tau, and eventually lead to destruction of the neuron. 5 Cholinergic deficits in AD have been well documented. 7 Insufficient levels of acetylcholine (Ach) at synapse will impair the neuromodulatory function of this neurotransmitter. 7 The reduction of Ach is correlated with the neuropathology and cognitive impairment.
Therapeutic Approaches Based on Pathologic Mechanism in Brain ( Fig. 1) 
Antioxidants
Vitamin E is known to be potent antioxidant properties and free radicals may contribute to the pathological processes of cognitive impairment. Sano et al. 8 improve cognitive function when compared with placebo. 17 While most women receiving estrogen plus progestin did not experience clinically relevant adverse effects on cognition compared with placebo, a small increased risk of clinically meaningful cognitive decline occurred in the estrogen plus progestin group. 17 Next year the effect of estrogenalone therapy, also evaluated in WHIMS. They concluded that for women aged 65 years or older, estrogen therapy had an adverse effect on cognition, which was greater among women with lower cognitive function at initiation of treatment. A healthy diet helps prevent hypertension (via reduced saturated fats and sodium), prediabetes (reduce sweets and caloric intake and consume more fibre), and stroke (dietary J MM change to reduce cholesterol). 30 There is evidence that individuals whose diets are high in omega-3 fatty acids, especially docosahexaenoic acid (DHA), have a 50% reduction in their risk of developing dementia. 33 About 180 mg of DHA daily intake is suggested and this amount can be achieved by eating the fish about three times per week. 30 And the potential for physical activity and exercise training to improve cognitive function is that women with higher levels of baseline physical activity were less likely to develop cognitive decline. 34, 35 About the mental activity, keeping the brain active by continuing to learn new skills is helpful to build cognitive reserve. 36 This staves off dementia.
Free radical damages can accelerate the brain aging, so by consuming antioxidants such as vitamin E will help the body quench free radical associated changes. 30 
Conclusion
The prevention and treatment of cognitive impairment has considered important within aging population. Interventions from lifestyle measures to pharmacological treatments may be beneficial for cognitive function. And recent studies suggest that physical exercise, mental activity, and nutritional supplements may reduce the risk of cognitive disorders and AD.
